systematic_review
    2010

    Galectin-3 inhibition with modified citrus pectin: mechanisms and therapeutic prospects

    Wang Y, Nangia-Makker P, Tait L

    Published in Journal of the National Cancer Institute

    Key Findings

    Modified citrus pectin binds galectin-3 and reduces tumour cell adhesion and metastasis in animal models.

    Conclusions

    Mechanistic case is stronger than the clinical case.

    Limitations

    Preclinical evidence base.

    Supplements Studied

    Modified citrus pectin binds galectin-3 and reduces tumour cell adhesion and metastasis in animal models.

    Study Details

    Year:2010
    Quality Score:5/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.